| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
REGULAR ARTICLES |

*
Divisions of Baxter Novum and Renal Medicine, Department of Clinical
Science, Huddinge University Hospital, Karolinska Institute,
Sweden.
Sophiahemmet Dialysis Unit, Stockholm, Sweden.
Correspondence to Dr. Jonas Bergström, Divisions of Baxter Novum and Renal Medicine, K-56, Huddinge University Hospital, Karolinska Institute, S-141 86 Huddinge, Sweden. Phone: 46 87 462607; Fax: 46 87 114742; E-mail: jonaberg{at}kfcd05.hs.sll.se
Abstract. In this investigation, sulfur amino acids (sAA) and
sulfhydryls were determined in the plasma and erythrocytes (RBC) of 10 uremic
patients on regular hemodialysis (HD) treatment and 10 healthy subjects,
before and after supplementation with 15 mg/d of folic acid and 200 mg/d of
pyridoxine for 4 wk. The basal total plasma concentrations of homocysteine
(Hcy), cysteine (Cys), cysteinylglycine (Cys-Gly),
-glutamylcysteine
(
-Glu-Cys), glutathione (GSH), and free cysteinesulfinic acid (CSA)
were significantly higher in HD patients when compared to healthy subjects,
whereas methionine (Met) and taurine (Tau) concentrations were the same in the
two groups. HD patients showed significantly higher RBC levels of Hcy and
Cys-Gly, whereas the RBC concentrations of Met, Cys, Tau, and GSH were not
different from those in the healthy subjects. The plasma concentrations of sAA
and sulfhydryls differed compared with RBC levels in the healthy subjects and
HD patients. In both groups, supplementation with high doses of folic acid and
pyridoxine reduced the plasma Hcy concentration. In addition, increased plasma
concentrations of Cys-Gly and GSH were found in the HD patients and of CSA in
the healthy subjects. After vitamin supplementation, the RBC concentrations of
Hcy, Cys, and GSH increased and that of Tau decreased in healthy subjects. The
only significant finding in RBC of HD patients was an increase in GSH levels
after supplementation. This study shows several RBC and plasma sAA and
sulfhydryl abnormalities in HD patients, which confirms earlier findings that
RBC and plasma pools play independent roles in interorgan amino acid transport
and metabolism. Moreover, high-dose supplementation with folic acid and
pyridoxine significantly reduced Hcy levels, but did not restore the sAA and
sulfhydryl abnormalities to normal levels. The increase that was observed in
GSH after vitamin supplementation may have a beneficial effect in improving
blood antioxidant status in uremic patients. Finally, the findings of elevated
plasma Cys levels correlating to the elevated plasma Hcy levels in the
presence of elevated plasma CSA levels, both before and after vitamin
supplementation, led to the hypothesis that a block in decarboxylation of CSA
is linked to hyperhomocysteinemia in end-stage renal failure.
This article has been cited by other articles:
![]() |
I. M. Frey, I. Rubio-Aliaga, A. Siewert, D. Sailer, A. Drobyshev, J. Beckers, M. H. de Angelis, J. Aubert, A. B. Hen, O. Fiehn, et al. Profiling at mRNA, protein, and metabolite levels reveals alterations in renal amino acid handling and glutathione metabolism in kidney tissue of Pept2-/- mice Physiol Genomics, February 12, 2007; 28(3): 301 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. van Guldener Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1161 - 1166. [Full Text] [PDF] |
||||
![]() |
S. R. Davis, E. P. Quinlivan, P. W. Stacpoole, and J. F. Gregory III Plasma Glutathione and Cystathionine Concentrations Are Elevated but Cysteine Flux Is Unchanged by Dietary Vitamin B-6 Restriction in Young Men and Women J. Nutr., February 1, 2006; 136(2): 373 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Santangelo, V. Witko-Sarsat, T. Drueke, and B. Descamps-Latscha Restoring glutathione as a therapeutic strategy in chronic kidney disease Nephrol. Dial. Transplant., August 1, 2004; 19(8): 1951 - 1955. [Full Text] [PDF] |
||||
![]() |
G. Garibotto, A. Sofia, S. Saffioti, R. Russo, G. Deferrari, D. Rossi, D. Verzola, M. T. Gandolfo, and M. R. Sala Interorgan exchange of aminothiols in humans Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E757 - E763. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Suliman, P. Barany, J. C. D. Filho, A. R. Qureshi, P. Stenvinkel, O. Heimburger, B. Anderstam, B. Lindholm, and J. Bergstrom Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease Nephrol. Dial. Transplant., June 1, 2002; 17(6): 1050 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Suliman, J. C. D. Filho, P. Barany, B. Anderstam, B. Lindholm, and J. Bergstrom Effects of methionine loading on plasma and erythrocyte sulphur amino acids and sulph-hydryls before and after co-factor supplementation in haemodialysis patients Nephrol. Dial. Transplant., January 1, 2001; 16(1): 102 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. SUNDER-PLASSMANN, M. FÖDINGER, H. BUCHMAYER, M. PAPAGIANNOPOULOS, J. WOJCIK, J. KLETZMAYR, B. ENZENBERGER, O. JANATA, W. C. WINKELMAYER, G. PAUL, et al. Effect of High Dose Folic Acid Therapy on Hyperhomocysteinemia in Hemodialysis Patients: Results of the Vienna Multicenter Study J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1106 - 1116. [Abstract] [Full Text] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673